Purple Biotech
(NASDAQ) KTOV
Purple Biotech Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$26.67
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
KTOV News
KTOV: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Purple Biotech
Industry
Pharmaceuticals
Sector
Health CareEmployees
10
CEO
Gil Efron, MBA, CPA
Website
www.purple-biotech.comKTOV Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
0%
Return on Assets
0%
Earnings Yield
N/A
Dividend Yield
N/A
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$1.00M
Operating Income
$0.00
EBITDA
$178.00K
Operating Cash Flow
$5.58M
Capital Expenditure
$0.00
Free Cash Flow
$5.58M
Cash & ST Invst.
$4.38M
Total Debt
$0.00
Purple Biotech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.05
+1.3%
Gross Margin
N/A
N/A
Market Cap
N/A
N/A
Market Cap/Employee
$0.61
N/A
Employees
10
N/A
Net Income
$23.79
+56.9%
EBITDA
$2.93
+3.0%
Quarterly Fundamentals
Net Cash
$8.72
+1.2%
Accounts Receivable
N/A
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.24
+1.3%
Return on Assets
-97.27%
+5.4%
Return on Invested Capital
-37.74%
+0.8%
Free Cash Flow
$1.54
+0.4%
Operating Cash Flow
$1.04
+0.5%